Tag: Strategic Pricing

Thank you, Dallas: Vistaar’s PPS 2018 Recap | Pricing Matters

Thank you, Dallas: Vistaar’s PPS 2018 Recap | Pricing Matters

Many thanks to those who joined Vistaar at the PPS Fall conference in Dallas. There were many interesting pricing topics discussed, with lots of opportunities to socialize. We took note of the topics that surfaced most frequently: Using real-world examples of AI in B2B & B2C pricing; How to use various solutions to capitalize on […]

Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure | Reuters

Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure | Reuters

COPENHAGEN (Reuters) – Novo Nordisk (NOVOb.CO), the world’s top maker of diabetes drugs, reported encouraging sales of its main growth drivers on Thursday as it announced more job cuts amid a restructuring to cope with intensifying pricing pressure in the United States. The logo of Danish multinational pharmaceutical company Novo Nordisk is pictured on the […]

Merck CEO on US healthcare system and drug pricing [Video] | CNBC

Merck CEO on US healthcare system and drug pricing [Video] | CNBC

Merck CEO Ken Frazier discusses the U.S. healthcare system and President Donald Trump’s drug pricing plan. Read complete article here: Merck CEO on US healthcare system and drug pricing.

Prescription Drug Prices: A Bitter Pill In The Midterm Elections | Forbes

Prescription Drug Prices: A Bitter Pill In The Midterm Elections | Forbes

All the campaign rhetoric leading up to Election Day 2018 next Tuesday is enough to give you a headache. Maybe that’s one reason why high prescription drug prices have become a major concern among older voters for the midterm elections. “This is a pain point,” said Tim Lash, chief strategy officer of West Health Institute […]

Prices vary within hospitals: Why patients should price shop payers | Becker’s Hospital Review

Prices vary within hospitals: Why patients should price shop payers | Becker’s Hospital Review

Research on price variation in healthcare often shows the stark differences patients pay for the same procedure at one hospital compared to another. However, a working paper published by the National Bureau of Economic Research suggests payers play an equally significant role in price variation, even within the same hospital. … For these five procedures, […]

Answering Your Questions about the IPI Drug Pricing Model | HHS

Answering Your Questions about the IPI Drug Pricing Model | HHS

How will this model affect patient access? Could this change my Medicare benefits? The IPI model does not include any restrictions on patient access or choice of drugs. This stands in marked contrast to proposals that would impose formularies in order to negotiate down drug prices. Given the size of the U.S. drug market and […]

The ‘vendors’ in HHS’ new drug pricing plan sound an awful lot like PBMs, experts say  | FierceHealthcare

The ‘vendors’ in HHS’ new drug pricing plan sound an awful lot like PBMs, experts say  | FierceHealthcare

Despite railing against the role of middlemen—namely pharmacy benefit managers—in rising drug prices, the Trump administration appears poised to introduce some of its own into the Part B program. The Department of Health and Human Services unveiled its International Pricing Index (IPI) model last week, which aims to bring down the costs of pharmaceuticals in […]

CLIP of the month: Does orphan drug pricing pose an antitrust problem? | The CLIP Board

CLIP of the month: Does orphan drug pricing pose an antitrust problem? | The CLIP Board

Both the US and EU have therefore sought to incentivise companies to develop orphan drugs. For example, in the US, the Orphan Drugs Act 1983 provides tax credits for clinical research into rare diseases, and the EU’s Horizon 2020 scheme provides funding of around €900 million for collaborative projects related to rare diseases. Although more […]

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | Becker’s ASC Review

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | Becker’s ASC Review

Almost every other industry has price transparency, and it is time for healthcare to catch up, said Stephen Blake, JD, CEO of Arlington, Texas-based Central Park ENT & Surgery Center. “We need to bend the cost curve. Price transparency should be our culture. Every other industry has the capability. We shouldn’t be the only industry […]

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | BEcker’s ASC

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | BEcker’s ASC

Almost every other industry has price transparency, and it is time for healthcare to catch up, said Stephen Blake, JD, CEO of Arlington, Texas-based Central Park ENT & Surgery Center. “We need to bend the cost curve. Price transparency should be our culture. Every other industry has the capability. We shouldn’t be the only industry […]